Dermatology · Opelika, AL
NPI
1265423313
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
122 N 20th St, Bldg 25
Opelika, AL, 36801
Phone (334) 749-5604
Groups this clinician bills Medicare through
Medicare paid, 2024
$305K
10,063 services
Medicare patients, 2024
1,021
Average age 76
Drug cost, 2024
$2.6M
3,387 prescriptions
Company payments, 2025
$1,294
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John A Stewart was code 17003 (destruction skin lesion), 5,754 times for 533 patients. In total John A Stewart billed 10,063 services in 76 codes, and Medicare paid $305K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 5,754 | 533 | $4.46 | $26K |
| 17000 Destruction Skin Lesion | Office | 866 | 614 | $27.94 | $24K |
| 17110 Destruction Skin Lesion | Office | 515 | 421 | $55.79 | $29K |
| 99213 Office E&M - Established | Office | 429 | 318 | $59.96 | $26K |
| 17282 Destruction Skin Lesion | Office | 373 | 209 | $101.38 | $38K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 274 | 70 | $0.66 | $180 |
| 17272 Destruction Skin Lesion | Office | 218 | 145 | $86.91 | $19K |
| 17262 Destruction Skin Lesion | Office | 158 | 106 | $79.55 | $13K |
| 11602 Skin Lesion Excision | Office | 111 | 82 | $134.67 | $15K |
| 11622 Skin Lesion Excision | Office | 106 | 82 | $142.21 | $15K |
| 11440 Skin Lesion Excision | Office | 88 | 65 | $68.19 | $6,000 |
| 11301 Removal or Shaving of Skin Growth | Office | 88 | 76 | $60.86 | $5,356 |
| 11102 Skin Biopsy | Office | 84 | 79 | $48.20 | $4,049 |
| 11302 Removal or Shaving of Skin Growth | Office | 76 | 70 | $68.41 | $5,199 |
| 11642 Skin Lesion Excision | Office | 69 | 59 | $151.38 | $10K |
By year: 2022 $314K for 11,160 services; 2023 $323K for 11,571 services; 2024 $305K for 10,063 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87101 General Laboratory | 25 | 22 | $6.95 | $174 |
Medicare prescription drug claims, 2024
In 2024, the drug John A Stewart prescribed most often to Medicare patients was Triamcinolone Acetonide, with 504 prescriptions and refills. In total John A Stewart wrote 3,387 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 504 | 557 | 285 | $4,935 |
| Clobetasol Propionate Generic | 376 | 407 | 218 | $18K |
| Fluorouracil Generic | 286 | 312 | 210 | $21K |
| Ketoconazole Generic | 144 | 191 | 89 | $2,133 |
| Minocycline Hcl Generic | 121 | 149 | 50 | $2,355 |
| Otezla Apremilast | 93 | 93 | 11 | $444K |
| Doxycycline Hyclate Generic | 93 | 97 | 76 | $809 |
| Dupixent Pen Dupilumab | 89 | 89 | 16 | $331K |
| Desonide Generic | 88 | 93 | 55 | $6,964 |
| Tretinoin Generic | 87 | 95 | 40 | $9,596 |
| Tacrolimus Generic | 83 | 86 | 51 | $7,077 |
| Terbinafine Hcl Generic | 83 | 129 | 52 | $619 |
| Fluocinonide Generic | 82 | 97 | 37 | $4,318 |
| Rinvoq Upadacitinib | 77 | 81 | 12 | $523K |
| Valacyclovir Valacyclovir Hcl | 71 | 85 | 36 | $2,606 |
Brand drugs: - claims; generic drugs: 2,855 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John A Stewart $1,294 ($1,294 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $293.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $293 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $213 |
| Genzyme Corporation SNY | 12 | $185 |
| UCB, Inc. UCB.BR | 16 | $176 |
| Janssen Biotech, Inc. JNJ | 10 | $145 |
| Pfizer Inc. PFE | 6 | $115 |
| Amgen Inc. AMGN | 3 | $65.51 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $27.75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22.25 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $18.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.